Open AccessAttenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy
Author(s) -
Yanjie You,
Fang-Rui Hu,
Shengjuan Hu
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13345
Subject(s) - cancer , molecular medicine , oncogene , oncology , biomarker , liver cancer , medicine , immunohistochemistry , in silico , survival analysis , cell cycle , biology , gene , biochemistry